View in EDS HTML Full Text PDF Full Text

Bortezomib, Thalidomide, and Dexamethasone (VTD) Induction Results in Better Overall Survival than Adriamycin, Thalidomide, and Dexamethasone (ATD) Induction in Previously Untreated Myeloma Patients Eligible for Transplants.

Saved in:
Bibliographic Details
Title: Bortezomib, Thalidomide, and Dexamethasone (VTD) Induction Results in Better Overall Survival than Adriamycin, Thalidomide, and Dexamethasone (ATD) Induction in Previously Untreated Myeloma Patients Eligible for Transplants.
Authors: Chen JF; Department of Evidence-Based Medicine and Clinical Epidemiology, Second Clinical College of Wuhan University, Wuhan, China., Xiao LF, Zhang R, Zeng ZH, Li YX, Meng XY
Source: Acta haematologica [Acta Haematol] 2017; Vol. 137 (4), pp. 207-208. Date of Electronic Publication: 2017 May 05.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28472803
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bortezomib, Thalidomide, and Dexamethasone (VTD) Induction Results in Better Overall Survival than Adriamycin, Thalidomide, and Dexamethasone (ATD) Induction in Previously Untreated Myeloma Patients Eligible for Transplants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+JF%22">Chen JF</searchLink>; Department of Evidence-Based Medicine and Clinical Epidemiology, Second Clinical College of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Xiao+LF%22">Xiao LF</searchLink><br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink><br /><searchLink fieldCode="AU" term="%22Zeng+ZH%22">Zeng ZH</searchLink><br /><searchLink fieldCode="AU" term="%22Li+YX%22">Li YX</searchLink><br /><searchLink fieldCode="AU" term="%22Meng+XY%22">Meng XY</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220141053%22">Acta haematologica</searchLink> [Acta Haematol] 2017; Vol. 137 (4), pp. 207-208. <i>Date of Electronic Publication: </i>2017 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0141053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1421-9662 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200015792%22">00015792 </searchLink><i>NLM ISO Abbreviation: </i>Acta Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28472803
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000471839
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 207
    Titles:
      – TitleFull: Bortezomib, Thalidomide, and Dexamethasone (VTD) Induction Results in Better Overall Survival than Adriamycin, Thalidomide, and Dexamethasone (ATD) Induction in Previously Untreated Myeloma Patients Eligible for Transplants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen JF
      – PersonEntity:
          Name:
            NameFull: Xiao LF
      – PersonEntity:
          Name:
            NameFull: Zhang R
      – PersonEntity:
          Name:
            NameFull: Zeng ZH
      – PersonEntity:
          Name:
            NameFull: Li YX
      – PersonEntity:
          Name:
            NameFull: Meng XY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1421-9662
          Numbering:
            – Type: volume
              Value: 137
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Acta haematologica
              Type: main
ResultId 1